CEMATRIX Announces $4.2 Million in New Contracts and a Net $3.1 Million Increase in New Contracts in Process
26 October 2022 - 11:25PM
CEMATRIX Corporation (TSXV: CVX) (OTCQB: CTXXF)
("
CEMATRIX" or the "
Company") a
North American leading manufacturer and supplier of technologically
advanced cellular concrete products announced that its wholly owned
operating subsidiaries, which include CEMATRIX (Canada) Inc.
(“CCI”), MixOnSite USA Inc. (“MOS”) and Pacific International Grout
Company (“PIGCO”) have executed $4.2 million in new contracts, and
have been awarded $3.1 million in other projects by way of letter
of intent upon which contracts are being processed.
Factoring in the $4.2M in contracts executed,
converted contracts, the new net contracts in process of $3.1
million and sales completed to date, the Corporation’s backlog
remains strong at $83.6 million. $34.7 million of the Corporation’s
backlog is now Contracted and $48.9 million is Contracts in
Process.
“The $4.2 million in contracts executed since
our last contract announcement and the net $3.1 million increase in
contracts in process are for geotechnical and tunnel infrastructure
projects across North America,” stated Jeff Kendrick, CEMATRIX
President and CEO. “Demand remains strong and is reflected in the
robust backlog total. We had a good quarter from a sales
perspective, and we expect sales for the balance of the year to
remain strong, provided our cement supply remains steady”.
“The severe cement shortage has had a major
impact across North American infrastructure projects over the past
year. Projects have been delayed, inflationary pressures have put
pressure on margins and there have been some missed opportunities
due to the cement shortage. Despite these challenges, CEMATRIX is
receiving the cement and ready-mix slurry requirements for most of
our projects. Our Company’s ability to secure sufficient cement and
ready-mix for these projects is a testament to the hard work and
dedication of our sales and project management staff and the strong
relationships we have developed with our suppliers including our
alliance partner,” concluded Mr Kendrick.
The Corporation’s Backlog is defined as
Contracted plus Contracts in Process net of sales completed to
date. Contracts in Process are defined as projects where the
related contract is in office for review or signature; or signed
and returned to the client for their signature; or is in the post
award project submission process; or is awarded by letter of
intent; or is awarded by some other form of written
communication.
ABOUT CEMATRIX
CEMATRIX is a rapidly growing company that
manufactures and supplies technologically advanced cellular
concrete products developed from proprietary formulations across
North America. This unique cement-based material with superior
thermal protection delivers cost-effective, innovative solutions to
a broad range of problems facing the infrastructure, industrial
(including oil and gas) and commercial markets. With the
acquisitions of Chicago based MixOnSite and Bellingham based
Pacific International Grout, has made CEMATRIX is now a true leader
in North America’s growing Cellular Concrete market. CEMATRIX’s
recent investment in Glavel Inc., of Burlington Vermont, a foamed
glass manufacturer, has strengthened CEMATRIX’s commitment to the
environment in the infrastructure construction space. For more
information, please visit our website at www.cematrix.com.
CAUTIONARY STATEMENT REGARDING FORWARD LOOKING
STATEMENTS
This news release contains forward-looking
statements and forward-looking information (together,
"forward-looking statements") within the meaning of applicable
securities laws. All statements, other than statements of
historical facts, are forward-looking statements. Generally,
forward-looking statements can be identified by the use of
terminology such as "plans", "expects", "estimates", "intends",
"anticipates", "believes" or variations of such words, or
statements that certain actions, events or results "may", "could",
"would", "might", "will be taken", "occur" or "be achieved". The
forward-looking statements contained in this news release are based
on certain key expectations and assumptions made by the Company,
including satisfaction of regulatory requirements in various
jurisdictions and the Company’s anticipated use of the net proceeds
of the Offering. Forward looking statements involve risks,
uncertainties and other factors disclosed under the heading "Risk
Factors" and elsewhere in the Company's filings with Canadian
securities regulators, which could cause actual results,
performance, prospects and opportunities to differ materially from
those expressed or implied by such forward-looking statements.
Although the Company believes that the
assumptions and factors used in preparing these forward-looking
statements are reasonable based upon the information currently
available to management as of the date hereof, actual results and
developments may differ materially from those contemplated by these
statements. Readers are therefore cautioned not to place undue
reliance on these statements, which only apply as of the date of
this news release, and no assurance can be given that such events
will occur in the disclosed times frames or at all. Except where
required by applicable law, the Company disclaims any intention or
obligation to update or revise any forward-looking statement,
whether as a result of new information, future events or
otherwise.
Neither TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in the policies of the TSX
Venture Exchange) accepts responsibility for the adequacy or
accuracy of this release.
For further information, please
contact:Jeff Kendrick - President and Chief Executive
Officer Phone: (403) 219-0484
Glen Akselrod – President, Bristol CapitalPhone: (905) 326 1888
ext 1glen@bristolir.com
Jeff Walker, The Howard Group – Investor
RelationsPhone: (888) 221-0915 or (403) 221-0915
jeff@howardgroupinc.com
Cematrix (TSXV:CVX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Cematrix (TSXV:CVX)
Historical Stock Chart
From Apr 2023 to Apr 2024